0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
100.00%
Revenue growth of 100.00% while ANO.AX is flat. Bruce Berkowitz would check if a small edge can widen further.
-45.66%
Negative gross profit growth while ANO.AX is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-92.42%
Negative EBIT growth while ANO.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-92.42%
Negative operating income growth while ANO.AX is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
100.00%
Net income growth of 100.00% while ANO.AX is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
200.00%
EPS growth of 200.00% while ANO.AX is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
50.00%
Diluted EPS growth of 50.00% while ANO.AX is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
2.52%
Share change of 2.52% while ANO.AX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
2.52%
Diluted share change of 2.52% while ANO.AX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative OCF growth while ANO.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-100.00%
Negative FCF growth while ANO.AX is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
131.31%
10Y revenue/share CAGR under 50% of ANO.AX's 316.75%. Michael Burry would suspect a lasting competitive disadvantage.
329.11%
5Y revenue/share CAGR above 1.5x ANO.AX's 135.59%. David Dodd would look for consistent product or market expansions fueling outperformance.
39.95%
3Y revenue/share CAGR above 1.5x ANO.AX's 10.86%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-102513.07%
Negative 10Y OCF/share CAGR while ANO.AX stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-807.57%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-188.10%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
24856.74%
Net income/share CAGR above 1.5x ANO.AX's 278.59% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
1928.87%
5Y net income/share CAGR above 1.5x ANO.AX's 791.01%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-26.66%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
94.41%
Below 50% of ANO.AX's 855.88%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
52.28%
Below 50% of ANO.AX's 285.87%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.46%
We have a declining book value while ANO.AX shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
8.96%
Debt growth of 8.96% while ANO.AX is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-32.55%
We cut SG&A while ANO.AX invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.